[go: up one dir, main page]

SV2006002347A - Compuestos de piridazinona - Google Patents

Compuestos de piridazinona

Info

Publication number
SV2006002347A
SV2006002347A SV2005002347A SV2005002347A SV2006002347A SV 2006002347 A SV2006002347 A SV 2006002347A SV 2005002347 A SV2005002347 A SV 2005002347A SV 2005002347 A SV2005002347 A SV 2005002347A SV 2006002347 A SV2006002347 A SV 2006002347A
Authority
SV
El Salvador
Prior art keywords
compounds
piridazinona
piridazinone
hapatitis
infections
Prior art date
Application number
SV2005002347A
Other languages
English (en)
Inventor
Yuefen Zhou
Liansheng Li
Stephen E Webber
Original Assignee
Anadys Pharmaceuticals Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Anadys Pharmaceuticals Inc filed Critical Anadys Pharmaceuticals Inc
Publication of SV2006002347A publication Critical patent/SV2006002347A/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing three or more hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D513/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00
    • C07D513/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00 in which the condensed system contains two hetero rings
    • C07D513/04—Ortho-condensed systems

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Virology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Communicable Diseases (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Oncology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Molecular Biology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

LA INVENCIÓN SE DIRIGE A COMPUESTOS DE PIRIDAZINONA Y COMPOSICIONES FARMACÉUTICAS QUE CONTIENEN TALES COMPUESTOS QUE SON ÚTILES EN EL TRATAMIENTO DE INFECCIONES POR VIRUS DE HAPATITIS C
SV2005002347A 2004-12-17 2005-12-19 Compuestos de piridazinona SV2006002347A (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US63661604P 2004-12-17 2004-12-17

Publications (1)

Publication Number Publication Date
SV2006002347A true SV2006002347A (es) 2006-08-25

Family

ID=36588590

Family Applications (1)

Application Number Title Priority Date Filing Date
SV2005002347A SV2006002347A (es) 2004-12-17 2005-12-19 Compuestos de piridazinona

Country Status (21)

Country Link
US (1) US7425552B2 (es)
EP (1) EP1824847A2 (es)
JP (1) JP2008526687A (es)
KR (1) KR20070100743A (es)
CN (1) CN101137651A (es)
AP (1) AP2007004040A0 (es)
AR (1) AR054214A1 (es)
AU (1) AU2005316396A1 (es)
CA (1) CA2589527A1 (es)
CR (1) CR9204A (es)
EA (1) EA200701297A1 (es)
GT (1) GT200500373A (es)
IL (1) IL183510A0 (es)
MX (1) MX2007007264A (es)
NO (1) NO20073105L (es)
PA (1) PA8657001A1 (es)
PE (1) PE20060871A1 (es)
SV (1) SV2006002347A (es)
TW (1) TW200635596A (es)
UY (1) UY29266A1 (es)
WO (1) WO2006066079A2 (es)

Families Citing this family (32)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7425552B2 (en) 2004-12-17 2008-09-16 Anadys Pharmaceuticals, Inc. Pyridazinone compounds
HRP20141053T1 (hr) 2005-05-10 2014-12-19 Intermune, Inc. Derivati piridona za moduliranje stresom aktiviranog sustava protein kinaze
WO2008051637A2 (en) * 2006-06-22 2008-05-02 Anadys Pharmaceuticals, Inc. Pyridazinone compounds
EP2038286B1 (en) * 2006-06-22 2017-03-08 Anadys Pharmaceuticals, Inc. Pyrro[1,2-b]pyridazinone compounds
CL2007003587A1 (es) 2006-12-12 2008-07-04 Anadys Pharmaceuticals Inc Compuestos derivados de pirimidinas sustituidas; composicion farmaceutica que comprende a dichos compuestos y otro agente activo; y su uso para tratar o prevenir la infeccion de la hepatitis c.
WO2008073987A1 (en) * 2006-12-12 2008-06-19 Anadys Pharmaceuticals, Inc. Saturated fused [1,2-b] pyridazinone compounds
US20080188466A1 (en) * 2006-12-21 2008-08-07 Anadys Pharmaceuticals, Inc. Pyridazinone compounds
WO2008082725A1 (en) * 2006-12-29 2008-07-10 Anadys Pharmaceuticals, Inc. Pyridazinone compounds
US20080227774A1 (en) * 2007-03-15 2008-09-18 Frank Ruebsam 5,5-disubstituted-indolizinone compounds
UA100120C2 (en) 2007-04-03 2012-11-26 Анадис Фармасьютикалз, Инк. 5,6-dihydro-1h-pyridin-2-one compounds
EP2142215B1 (en) 2007-05-04 2012-03-07 Vertex Pharmceuticals Incorporated Combination therapy for the treatment of hcv infection
WO2008144500A2 (en) * 2007-05-17 2008-11-27 Anadys Pharmaceuticals, Inc. 1-methyl-benzo[1,2,4]thiadiazine, 1-oxide derivatives
ITMI20071012A1 (it) * 2007-05-18 2008-11-19 St Microelectronics Srl Dispositivo di memoria migliorato a veloce programmazione
US7834009B2 (en) * 2007-08-27 2010-11-16 Anadys Pharmaceuticals, Inc. 4-hydroxy-5,6-dihydro-1H-pyridin-2-one compounds
CN102099036B (zh) 2008-06-03 2015-05-27 英特芒尼公司 用于治疗炎性疾患和纤维化疾患的化合物和方法
TWI438206B (zh) * 2008-06-10 2014-05-21 Anadys Pharmaceuticals Inc 〔１，２，４〕噻二１，１二氧化物化合物
US20110229438A1 (en) * 2008-10-09 2011-09-22 Anadys Pharmaceuticals, Inc. Method of inhibiting hepatitus c virus by combination of a 5,6-dihydro-1h-pyridin-2-one and one or more additional antiviral compounds
TW201026675A (en) * 2008-10-09 2010-07-16 Anadys Pharmaceuticals Inc 5,6-dihydro-1H-pyridin-2-one compounds
WO2010082050A1 (en) 2009-01-16 2010-07-22 Istituto Di Ricerche Di Biologia Molecolare P. Angeletti S.P.A. Macrocyclic and 7-aminoalkyl-substituted benzoxazocines for treatment of hepatitis c infections
WO2011045271A1 (de) 2009-10-15 2011-04-21 Bayer Cropscience Ag Herbizid wirksame heterocyclylsubstituierte pyridazinone
KR20120092142A (ko) 2009-10-28 2012-08-20 애나디스 파마슈티칼스, 인코포레이티드 중수소화 5,6-다이하이드로-1ｈ-파이리딘-2-온 화합물
PH12012501216A1 (en) 2009-12-18 2012-11-05 Boehringer Ingelheim Int Hcv combination therapy
WO2012158271A1 (en) 2011-04-06 2012-11-22 Anadys Pharmaceuticals, Inc. Bridged polycyclic compounds as antiviral agents
AR092742A1 (es) 2012-10-02 2015-04-29 Intermune Inc Piridinonas antifibroticas
WO2014121418A1 (en) 2013-02-07 2014-08-14 Merck Sharp & Dohme Corp. Tetracyclic heterocycle compounds and methods of use thereof for the treatment of hepatitis c
WO2014121417A1 (en) 2013-02-07 2014-08-14 Merck Sharp & Dohme Corp. Tetracyclic heterocycle compounds and methods of use thereof for the treatment of hepatitis c
WO2014121416A1 (en) 2013-02-07 2014-08-14 Merck Sharp & Dohme Corp. Tetracyclic heterocycle compounds and methods of use thereof for the treatment of hepatitis c
JP6525437B2 (ja) 2014-04-02 2019-06-05 インターミューン， インコーポレイテッド 抗線維性ピリジノン
PT3137456T (pt) * 2014-04-29 2021-08-06 Fmc Corp Herbicidas de piridazinona
JP6428951B2 (ja) * 2015-12-07 2018-11-28 Dic株式会社 重合性化合物の製造方法
CN105999097A (zh) * 2016-07-08 2016-10-12 王恩禄 一种治疗乙肝的中药组合物
US20220233542A1 (en) * 2019-06-05 2022-07-28 University Of Georgia Research Foundation Compositions and methods for preventing or treating human immunodeficiency virus associated pulmonary arterial hypertension

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5954047A (en) * 1997-10-17 1999-09-21 Systemic Pulmonary Development, Ltd. Methods and apparatus for delivering aerosolized medication
JP2004509066A (ja) 2000-05-10 2004-03-25 スミスクライン・ビーチャム・コーポレイション 新規抗感染症薬
US20060003346A1 (en) 2000-08-11 2006-01-05 Ashok Amin Method for treating hepatitis
AR036081A1 (es) 2001-06-07 2004-08-11 Smithkline Beecham Corp Compuesto de 1,2-dihidroquinolina, su uso para preparar una composicion farmaceutica, metodos para prepararlo y compuestos del acido 2-aminobenzoico n-alquilado de utilidad como intermediarios en dichos metodos
AU2002365198A1 (en) 2001-10-30 2003-07-30 Smithkline Beecham Corporation Novel anti-infectives
US7601709B2 (en) 2003-02-07 2009-10-13 Enanta Pharmaceuticals, Inc. Macrocyclic hepatitis C serine protease inhibitors
US7439246B2 (en) 2004-06-28 2008-10-21 Bristol-Myers Squibb Company Fused heterocyclic kinase inhibitors
WO2006021340A1 (en) 2004-08-23 2006-03-02 F.Hoffmann-La Roche Ag Heterocyclic antiviral compounds
US7425552B2 (en) 2004-12-17 2008-09-16 Anadys Pharmaceuticals, Inc. Pyridazinone compounds
BRPI0607533A2 (pt) 2005-04-21 2009-09-15 Nippon Shinyaku Co Ltd derivado de ftalazinona, composição farmacêutica, inibidor de fosfodiesterase do tipo 4,supressor da produção de tnf-alfa, agente preventivo ou terapêutico, preparado externo, bem como uso do referido derivado
KR20070116682A (ko) * 2005-05-04 2007-12-10 에프. 호프만-라 로슈 아게 헤테로사이클릭 항바이러스성 화합물
EP2038286B1 (en) 2006-06-22 2017-03-08 Anadys Pharmaceuticals, Inc. Pyrro[1,2-b]pyridazinone compounds

Also Published As

Publication number Publication date
CN101137651A (zh) 2008-03-05
JP2008526687A (ja) 2008-07-24
US7425552B2 (en) 2008-09-16
AR054214A1 (es) 2007-06-13
US20060189602A1 (en) 2006-08-24
PA8657001A1 (es) 2006-08-03
IL183510A0 (en) 2007-09-20
AP2007004040A0 (en) 2007-06-30
CR9204A (es) 2007-09-06
GT200500373A (es) 2006-10-02
PE20060871A1 (es) 2006-09-04
CA2589527A1 (en) 2006-06-22
KR20070100743A (ko) 2007-10-11
EP1824847A2 (en) 2007-08-29
EA200701297A1 (ru) 2007-12-28
TW200635596A (en) 2006-10-16
WO2006066079A3 (en) 2006-12-14
UY29266A1 (es) 2006-07-31
WO2006066079A2 (en) 2006-06-22
AU2005316396A1 (en) 2006-06-22
NO20073105L (no) 2007-09-13
MX2007007264A (es) 2007-08-14

Similar Documents

Publication Publication Date Title
SV2006002347A (es) Compuestos de piridazinona
PA8733401A1 (es) Compuestos de pirro[1,2-b]piridazinona
GT201200257A (es) Composiciones sólidas
DK2250163T3 (da) Hepatitis C-virusinhibitorer
CO6290682A2 (es) Compuestos triciclicos fusionados inhibidores del virus de la hepatitis c.
EA200970916A1 (ru) Соединения 5,6-дигидро-1н-пиридин-2-она
CL2013002299A1 (es) Compuestos derivados de heterociclos, inhibidores de la replicacion del virus de la hepatitis c; composicion farmaceutica que los comprende; util en el tratamiento de una infeccion por vhc. (divisional solicitud 689-2011).
EA200800178A1 (ru) Ингибиторы вируса гепатита с (hcv)
UY30778A1 (es) Compuestos de 5,6-dihidro-1h-piridin-2-ona
CL2012002489A1 (es) Compuestos derivados de sililo nafto-imidazol; composición farmacéutica; y su uso para prevenir o tratar una infección por el virus de la hepatitis c.
CL2015000870A1 (es) Análogos de 2' -cloro nucleósido para infección por vhc.
SV2005001920A (es) " compuestos nucleosidos para el tratamiento de infecciones virales "
HN2009000792A (es) Inhibidores de la proteasa ns3 del hcv
DOP2009000094A (es) Inhibidores de la proteasa ns3 del hcv
CO6400192A2 (es) Inhibidores del virus de la hepatitis c
EA200870164A1 (ru) Лечение вирусного гепатита
EA200701849A1 (ru) Пролекарственные соединения трициклических нуклеозидов, фармацевтическая композиция на их основе и способ лечения и/или ингибирования вирусной инфекции у млекопитающего
CY1113102T1 (el) Ενωσεις φαινυλπροπιοναμιδιου και η χρηση αυτων
UY29007A1 (es) Derivados de 2-carbamida-4-feniltiazol, su preparacinn, y su aplicacinn en terapcutica
PA8719401A1 (es) Compuestos de tetrahidropiridotienopirimidina y metodos para su empleo
ATE533774T1 (de) Neuartige nukleosidanaloge zur behandlung von virusinfektionen
EA201000277A1 (ru) Соединения для лечения гепатита с
EA201170605A1 (ru) Циклоундекадепсипептидные соединения и применение указанных соединений в качестве лекарственного средства
SV2005001919A (es) Compuestos nucleosidos para el tratamiento de infecciones virales
GT200600262A (es) Uso de la sangliferina en el hcv (virus de la hepatitis "c")